Highlights
NASDAQ: APTX       Aptinyx Inc
Last Price Today's Change   Day's Range   Trading Volume
4.235   -0.015 (0.35%)  4.22 - 4.33  15,567

Overview

 
Avg Volume (4 weeks):578,944
4 Weeks Range:2.95 - 5.25
4 Weeks Price Volatility (%):
55.87%
52 Weeks Range:2.61 - 6.00
52 Weeks Price Volatility (%):
47.94%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a novel, oral, small-molecule NMDA receptor modulator in clinical development as a therapy for chronic pain. NYX-2925 works by enhancing synaptic plasticity, a mechanism uniquely suited to addressing chronic pain, and NYX-783 is an NMDA receptor modulating small molecule in clinical development as a therapy for post-traumatic stress disorder.

  Be the first to like this.
 


 

2732  2306  707  3219 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 ACHN 6.760.00 
 AVP 5.60-0.05 
 GE 12.57+0.84 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 ECA 3.79-0.25 
 BBT 54.24+0.75 
 AMD 47.421-3.109 
 STI 70.13+0.87 
Partners & Brokers